NOVARTIS AG's ticker is and the CUSIP is 007103065. A total of 1 filers reported holding NOVARTIS AG in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $29,440,000 | +5.2% | 323,370 | +5.3% | 0.05% | +14.9% |
| Q4 2021 | $27,993,000 | +24.6% | 307,138 | +14.1% | 0.05% | +11.9% |
| Q3 2021 | $22,468,000 | +11.9% | 269,238 | +22.2% | 0.04% | +10.5% |
| Q2 2021 | $20,081,000 | -25.4% | 220,384 | -35.6% | 0.04% | -30.9% |
| Q1 2021 | $26,909,000 | -8.4% | 342,168 | +0.2% | 0.06% | -24.7% |
| Q4 2020 | $29,384,000 | +117.2% | 341,442 | +113.5% | 0.07% | +78.0% |
| Q3 2020 | $13,530,000 | +11.6% | 159,914 | +14.8% | 0.04% | 0.0% |
| Q2 2020 | $12,119,000 | +26.9% | 139,244 | +21.2% | 0.04% | +2.5% |
| Q1 2020 | $9,549,000 | +10.6% | 114,878 | +26.5% | 0.04% | +42.9% |
| Q4 2019 | $8,632,000 | +25.5% | 90,818 | +14.5% | 0.03% | -22.2% |
| Q3 2019 | $6,879,000 | +1.2% | 79,310 | +6.6% | 0.04% | -5.3% |
| Q2 2019 | $6,796,000 | +3.2% | 74,384 | +8.7% | 0.04% | -2.6% |
| Q1 2019 | $6,588,000 | +60.9% | 68,454 | +42.4% | 0.04% | +39.3% |
| Q4 2018 | $4,094,000 | +1.8% | 48,058 | +2.8% | 0.03% | +21.7% |
| Q3 2018 | $4,020,000 | +19.3% | 46,764 | +5.5% | 0.02% | +9.5% |
| Q2 2018 | $3,369,000 | +24.2% | 44,338 | +32.4% | 0.02% | +16.7% |
| Q1 2018 | $2,712,000 | +20.6% | 33,491 | +25.9% | 0.02% | +12.5% |
| Q4 2017 | $2,249,000 | -0.2% | 26,600 | +1.1% | 0.02% | -5.9% |
| Q3 2017 | $2,253,000 | – | 26,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aristotle Capital Management, LLC | 220,384 | $20,081,000 | 0.04% |